HIGH-DOSE PYRIDOXINE AND MAGNESIUM ADMINISTRATION IN CHILDREN WITH AUTISTIC DISORDER: AN ABSENCE OF SALUTARY EFFECTS IN A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Documenti analoghi

• A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER PILOT TRIAL OF LOW DOSE DIMETHYLGLYCINE IN PATIENTS WITH AUTISTIC DISORDER
  di: BOLMAN, W.M
  Pubblicazione: (1999)
• NALTREXONE IN YOUNG AUTISTIC CHILDREN: A DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER STUDY
  di: KOLMEN, B.K
  Pubblicazione: (1996)
• MULTISITE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PORCINE SECRETIN IN AUTISM
  di: OWLEY, T.
  Pubblicazione: (2002)
• EFFECTS OF NALOXONE AND NALTREXONE ON SELF-INJURY: A DOUBLE-BLIND, PLACEBO-CONTROLLED ANALYSIS
  di: BARRETT, R.P
  Pubblicazione: (1989)
• PYRIDOXINE-DEPENDENT SEIZURES: DEMOGRAPHIC, CLINICAL, MRI AND PSYCHOMETRIC FEATURES, AND EFFECT OF DOSE ON INTELLIGENCE QUOTIENT
  di: BAXTER, P.
  Pubblicazione: (1998)